Stocks and Investing Stocks and Investing
Tue, February 8, 2022
[ 12:00 AM ] - WOPRAI
Kenneth Zaslow Maintained (TSN) at Buy with Increased Target to $115 on, Feb 8th, 2022
[ 12:00 AM ] - WOPRAI
Peter Galbo Maintained (TSN) at Hold with Increased Target to $100 on, Feb 8th, 2022
[ 12:00 AM ] - WOPRAI
Andrew Kuske Downgraded (TRP) to Hold on, Feb 8th, 2022
[ 12:00 AM ] - WOPRAI
Arvind Ramnani Maintained (CHGG) at Buy with Increased Target to $44 on, Feb 8th, 2022
[ 12:00 AM ] - WOPRAI
Alex Fuhrman Maintained (CHGG) at Hold with Decreased Target to $35 on, Feb 8th, 2022
[ 12:00 AM ] - WOPRAI
Josh Baer Maintained (CHGG) at Hold with Increased Target to $37 on, Feb 8th, 2022
[ 12:00 AM ] - WOPRAI
Angie Storozynski Initiated (CEG) at Strong Buy and Held Target at $51 on, Feb 8th, 2022
[ 12:00 AM ] - WOPRAI
Julio Romero Upgraded (SSD) to Strong Buy and Held Target at $152 on, Feb 8th, 2022
[ 12:00 AM ] - WOPRAI
Daniel Moore Upgraded (SSD) to Buy on, Feb 8th, 2022
[ 12:00 AM ] - WOPRAI
Jessica Ehrlich Maintained (SPOT) at Strong Buy with Decreased Target to $262 on, Feb 8th, 2022
[ 12:00 AM ] - WOPRAI
Haendel St. Juste Maintained (SPG) at Hold with Decreased Target to $158 on, Feb 8th, 2022
[ 12:00 AM ] - WOPRAI
Jailendra Singh Downgraded (SLQT) to Hold and Decreased Target to $4 on, Feb 8th, 2022
[ 12:00 AM ] - WOPRAI
Jeff Garro Downgraded (SLQT) to Hold and Decreased Target to $4 on, Feb 8th, 2022
[ 12:00 AM ] - WOPRAI
Frank Morgan Maintained (SLQT) at Hold with Decreased Target to $3 on, Feb 8th, 2022
[ 12:00 AM ] - WOPRAI
Barry Oxford Initiated (SMRT) at Strong Buy and Held Target at $9 on, Feb 8th, 2022
[ 12:00 AM ] - WOPRAI
Jiong Shao Initiated (XPEV) at Buy on, Feb 8th, 2022
[ 12:00 AM ] - WOPRAI
Tyler Parker Maintained (TTWO) at Buy with Increased Target to $190 on, Feb 8th, 2022
[ 12:00 AM ] - WOPRAI
Drew Crum Maintained (TTWO) at Strong Buy and Held Target at $232 on, Feb 8th, 2022
[ 12:00 AM ] - WOPRAI
Brian Fitzgerald Maintained (TTWO) at Buy and Held Target at $225 on, Feb 8th, 2022
[ 12:00 AM ] - WOPRAI
James West Initiated (VAL) at Buy and Held Target at $72 on, Feb 8th, 2022
[ 12:00 AM ] - WOPRAI
Rupesh Parikh Downgraded (UTZ) to Hold on, Feb 8th, 2022
[ 12:00 AM ] - WOPRAI
Fatima Boolani Maintained (VRNS) at Strong Buy with Decreased Target to $55 on, Feb 8th, 2022
[ 12:00 AM ] - WOPRAI
Daniel Ives Maintained (VRNS) at Buy with Decreased Target to $60 on, Feb 8th, 2022
[ 12:00 AM ] - WOPRAI
Amit Dayal Maintained (WPRT) at Strong Buy on, Feb 8th, 2022
[ 12:00 AM ] - WOPRAI
Michael Lasser Maintained (WMT) at Strong Buy and Held Target at $60 on, Feb 8th, 2022
Mon, February 7, 2022
[ 12:00 AM ] - WOPRAI
Edward Kelly Maintained (WMT) at Buy and Held Target at $55 on, Feb 7th, 2022
[ 12:00 AM ] - WOPRAI
Tim Long Maintained (UI) at Sell with Decreased Target to $214 on, Feb 7th, 2022
[ 12:00 AM ] - WOPRAI
Hamed Khorsand Maintained (UI) at Strong Buy with Decreased Target to $345 on, Feb 7th, 2022
[ 12:00 AM ] - WOPRAI
Puneet Souda Maintained (TWST) at Hold with Decreased Target to $70 on, Feb 7th, 2022
[ 12:00 AM ] - WOPRAI
Luke Sergott Maintained (TWST) at Buy with Decreased Target to $75 on, Feb 7th, 2022

Luke Sergott Maintained (TWST) at Buy with Decreased Target to $75 on, Feb 7th, 2022


Published on 2024-10-27 19:35:59 - WOPRAI, Luke Sergott
  Print publication without navigation


Luke Sergott of Barclays, Maintained "Twist Bioscience Corporation" (TWST) at Buy with Decreased Target from $130 to $75 on, Feb 7th, 2022.

Luke, nor any peers, have made any analyst calls on TWST in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources